期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Protective Effects of Self-made Compound Taoren Danshen Decoction on Rats with Acute Liver Injury
1
作者 Yuman GUAN Kefeng ZHANG +2 位作者 Ya GAO Jiani LI Lin ZHANG 《Medicinal Plant》 CAS 2018年第5期107-110,共4页
[Objectives] To study the protective effects of self-made Compound Taoren Danshen Decoction( CTDD) on acute liver injury induced by D-galactosamine in rats,and to explore its mechanism. [Methods]An acute liver injury ... [Objectives] To study the protective effects of self-made Compound Taoren Danshen Decoction( CTDD) on acute liver injury induced by D-galactosamine in rats,and to explore its mechanism. [Methods]An acute liver injury model was established by intraperitoneal injection of 500 mg/kg of D-galactosamine. The ALT,AST,MDA,SOD and GSH-Px in serum,as well as serum TNF-α,IL-1β and IL-6 levels were measured,and liver tissue lesions were observed under microscope. [Results] CTDD can significantly reduce ALT,AST and MDA levels,increase SOD,GSH-Px activity,and significantly reduce serum TNF-α,IL-1β and IL-6 levels,and improve liver tissue lesions.[Conclusions]CTDD has a protective effect on D-galactosamine-induced acute liver injury in rats,and its mechanism may be related to inhibition of oxidative stress and inflammatory reaction. 展开更多
关键词 self-made COMPOUND Taoren DANSHEN decoction(CTDD) D-GALACTOSAMINE Acute liver injury Oxidative stress INFLAMMATORY reaction
下载PDF
Observation on Curative Effect of Self-made Wubeizi Decoction Combined with rhaFGF in Promoting Postoperative Wound Healing in Patients with Anal Fistula
2
作者 Yingnan YANG Dan GAN +2 位作者 Zhiqiang YUAN Dongqin WANG Yu CHEN 《Medicinal Plant》 CAS 2023年第3期74-77,81,共5页
[Objectives]To explore the curative effect of Self-made Wubeizi Decoction combined with recombinant human acidic fibroblast growth factor(rhaFGF)in promoting postoperative wound healing in patients with anal fistula.[... [Objectives]To explore the curative effect of Self-made Wubeizi Decoction combined with recombinant human acidic fibroblast growth factor(rhaFGF)in promoting postoperative wound healing in patients with anal fistula.[Methods]A total of 82 patients with anal fistula who underwent anal fistula resection+use of setons in Luodian Hospital during January and March of 2020 were randomly divided into observation group and control group with 41 cases in each group.The control group was given rhaFGF external application regimen,and the observation group was treated with Self-made Wubeizi Decoction on the basis of the control group.After 3 weeks of treatment,the differences in curative effects of TCM syndromes were compared between the two groups.Besides,the changes in TCM symptom scores,inflammatory mediators[interleukin-12(IL-12),tumor necrosis factor-α(TNF-α),interferon-γ(IFN-γ)],anorectal functions[anal resting pressure(ARP),maximal systolic pressure(MSP)and maximum tolerated volume(MTV)of the anal canal],quality of life[GQOLI-74 scores]were compared.[Results]After 3 weeks of treatment,the total effective rate of the observation group was significantly higher than that of the control group(P<0.05);the levels of TCM symptom scores,IL-12,TNF-α,IFN-γ,ARP,MSP,and MTV in both groups were significantly lower than those before treatment,and these levels in the observation group was significantly lower than that in the control group at the same time(P<0.05).The GQOLI-74 scores of both groups were significantly higher than those before treatment,and the observation group was significantly higher than the control group(P<0.05).[Conclusions]The Self-made Wubeizi Decoction combined with rhaFGF therapy has a significant effect in promoting postoperative wound healing in patients with anal fistula.It can effectively inhibit the local inflammation of patients,facilitate the recovery of anorectal function and improve the quality of life,thus has high clinical application value. 展开更多
关键词 self-made Wubeizi decoction Recombinant human acidic fibroblast growth factor(rhaFGF) Anal fistula Anal fistula resection Wound healing Inflammatory mediators Anorectal function Quality of life
下载PDF
自拟通络散联合来氟米特治疗风寒湿痹型类风湿关节炎疗效及对血清Wnt-3α和BMP-2水平的影响 被引量:12
3
作者 方兴刚 汪嫚 +3 位作者 陈汉玉 柏仲喜 陈曾凤 兰培敏 《现代中西医结合杂志》 CAS 2019年第13期1408-1411,1453,共5页
目的观察自拟通络散联合来氟米特治疗风寒湿痹型类风湿关节炎患者的临床疗效及对血清分泌型糖蛋白(Wnt-3α)、骨形成蛋白-2(BMP-2)水平的影响,为该病的有效治疗提供依据。方法将114例风寒湿痹型类风湿关节炎患者随机分为研究组与对照组... 目的观察自拟通络散联合来氟米特治疗风寒湿痹型类风湿关节炎患者的临床疗效及对血清分泌型糖蛋白(Wnt-3α)、骨形成蛋白-2(BMP-2)水平的影响,为该病的有效治疗提供依据。方法将114例风寒湿痹型类风湿关节炎患者随机分为研究组与对照组各57例。对照组给予西药塞来昔布、来氟米特治疗,研究组在对照组治疗基础上联合自拟通络散治疗,2组均连续治疗3个月后统计临床疗效,观察2组治疗前后中医证候积分及类风湿因子(RF)、红细胞沉降率(ESR)、C反应蛋白(CRP)、BMP-2、Wnt-3α水平变化情况。结果治疗3个月后,研究组患者总有效率为96.49%,显著高于对照组的80.70%(P<0.05);2组中医证候积分及RF、ESR、CRP水平均明显降低(P均<0.05),且研究组均明显低于对照组(P均<0.05);研究组血清BMP-2、Wnt-3α水平均明显低于治疗前及对照组(P均<0.05),对照组治疗前后血清BMP-2、Wnt-3α水平比较差异无统计学意义(P>0.05);研究组不良反应发生率为5.26%,对照组为33.33%,研究组显著低于对照组(P<0.05)。结论自拟通络散联合常规西药治疗风寒湿痹型类风湿关节炎病情缓解率明显高于单纯西药治疗,且安全,可能与有效调节血清BMP-2、Wnt-3α表达水平有关。 展开更多
关键词 自拟通络散 来氟米特 类风湿关节炎 骨形成蛋白-2 分泌型糖蛋白
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部